Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Evans

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 15, 2019
What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?Marc Evans, Angharad R Morgan, Zaheer Yousef
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 22, 2019
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome TrialsDavid M Williams, Asif Nawaz, Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 17, 2020
Drug Therapy in Obesity: A Review of Current and Emerging TreatmentsDavid M Williams, Asif Nawaz, Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2020
Diabetes and Novel Coronavirus Infection: Implications for TreatmentDavid M Williams, Asif Nawaz, Marc Evans
Current Medical Research and Opinion|March 18, 2016
Hypoglycemia, diabetes therapies and driving categories in type 2 diabetesMichael D Feher, Haya Langerman, Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 25, 2016
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care PerspectiveMarc Evans, Jens Gundgaard, Brian Bekker Hansen
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 5, 2021
The Value of Insulin Degludec in Frail Older Adults with Type 2 DiabetesW David Strain, Angharad R Morgan, Marc Evans
The New Zealand Medical Journal|February 12, 2008
Dumping syndrome presenting three decades after vagotomyCatherine Patton, Onyebuchi E Okosieme, L Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 12, 2018
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK SettingMarc Evans, Roopa Mehta, Jens Gundgaard, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 26, 2021
One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes MellitusMarc Evans, Angharad R Morgan, Stephen C Bain
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 15, 2019
What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?Marc Evans, Angharad R Morgan, Zaheer Yousef
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 22, 2019
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome TrialsDavid M Williams, Asif Nawaz, Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 17, 2020
Drug Therapy in Obesity: A Review of Current and Emerging TreatmentsDavid M Williams, Asif Nawaz, Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 15, 2020
Diabetes and Novel Coronavirus Infection: Implications for TreatmentDavid M Williams, Asif Nawaz, Marc Evans
Current Medical Research and Opinion|March 18, 2016
Hypoglycemia, diabetes therapies and driving categories in type 2 diabetesMichael D Feher, Haya Langerman, Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 25, 2016
Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care PerspectiveMarc Evans, Jens Gundgaard, Brian Bekker Hansen
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 5, 2021
The Value of Insulin Degludec in Frail Older Adults with Type 2 DiabetesW David Strain, Angharad R Morgan, Marc Evans
The New Zealand Medical Journal|February 12, 2008
Dumping syndrome presenting three decades after vagotomyCatherine Patton, Onyebuchi E Okosieme, L Marc Evans
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 12, 2018
Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK SettingMarc Evans, Roopa Mehta, Jens Gundgaard, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 26, 2021
One Hundred Years of Insulin: Value Beyond Price in Type 2 Diabetes MellitusMarc Evans, Angharad R Morgan, Stephen C Bain
Pageof 16